A chromatin immunoprecipitation (ChIP) assay further confirmed ZNF703 protein was enriched to the second ZNF703-binding site in the CLDN4 promoter in HCC cells (Fig. 3D). Here, ZNF703 is linked to hepatocellular carcinoma.